FMP

FMP

Healthpeak Properties, Inc. (NYSE: DOC) Downgraded by Jefferies Amid Mixed Investor Sentiment

  • Jefferies downgraded Healthpeak Properties, Inc. (NYSE: DOC) from a Buy to a Hold, reflecting a cautious approach towards the healthcare REIT.
  • Cullen Capital Management LLC reduced its stake in Healthpeak Properties by 5%, indicating a conservative stance, while Brooklyn Investment Group significantly increased its holdings.
  • The stock's volatility is highlighted by its year-to-year performance, with a high of $21.28 and a low of $16.44, amidst a market capitalization of approximately $11.58 billion.

Healthpeak Properties, Inc. (NYSE: DOC) is a real estate investment trust (REIT) that specializes in the healthcare real estate sector. The company is engaged in the acquisition, development, and management of healthcare properties across the United States, competing with other healthcare REITs like Welltower and Ventas.

On December 15, 2025, Jefferies downgraded Healthpeak Properties from a Buy to a Hold, with the stock priced at $16.66. This downgrade suggests a more cautious perspective from Jefferies towards the stock. Despite this, the stock price experienced a slight increase of approximately 0.24% or $0.04, fluctuating between $16.57 and $16.84 during the trading session.

Cullen Capital Management LLC has decreased its investment in Healthpeak Properties by 5% in the latest quarter, according to its 13F filing with the SEC. The firm now possesses 9.59 million shares, making up about 1.9% of its portfolio. This move mirrors the cautious approach taken by Jefferies.

Conversely, Brooklyn Investment Group has shown a bullish stance on Healthpeak Properties, increasing its stake by 198.9% in the first quarter, now holding 1,312 shares valued at $27,000. This demonstrates a mixed sentiment among investors regarding the stock's future potential.

With a market capitalization of approximately $11.58 billion and a trading volume of 5.18 million shares, Healthpeak Properties showcases significant volatility. Over the past year, the stock has seen a high of $21.28 and a low of $16.44, reflecting the diverse investor sentiment surrounding the company.